The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2
Abstract
Previous studies have reported that uric acid stimulates vascular smooth muscle cell (VSMC) proliferation in vitro. We hypothesized that uric acid may also have direct proinflammatory effects on VSMCs. Crystal- and endotoxin-free uric acid was found to increase VSMC monocyte chemoattractant protein-1 (MCP-1) expression in a time- and dose-dependent manner, peaking at 24 hours. Increased mRNA and protein expression occurred as early as 3 hours after uric acid incubation and was partially dependent on posttranscriptional modification of MCP-1 mRNA. In addition, uric acid activated the transcription factors nuclear factor-κB and activator protein-1, as well as the MAPK signaling molecules ERK p44/42 and p38, and increased cyclooxygenase-2 (COX-2) mRNA expression. Inhibition of p38 (with SB 203580), ERK 44/42 (with UO126 or PD 98059), or COX-2 (with NS398) each significantly suppressed uric acid–induced MCP-1 expression at 24 hours, implicating these pathways in the response to uric acid. The ability of both n -acetyl-cysteine and diphenyleneionium (antioxidants) to inhibit uric acid–induced MCP-1 production suggested involvement of intracellular redox pathways. Uric acid regulates critical proinflammatory pathways in VSMCs, suggesting it may have a role in the vascular changes associated with hypertension and vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,382
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992
Fang, J., & Alderman, M. H. (2000) · JAMA · doi:10.1001/jama.283.18.2404 · Cited by 1,513
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Self-citationElevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Self-citationSerum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
Culleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00003 · Cited by 1,282
Monocyte chemoattractant protein-1 in human atheromatous plaques.
Nelken, N. A., Coughlin, S. R., Gordon, D., & Wilcox, J. N. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115411 · Cited by 880
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K. L., Watanabe, S., Nakagawa, T., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00283.2001 · Cited by 826
Self-citationUric Acid, Hominoid Evolution, and the Pathogenesis of Salt-Sensitivity
Watanabe, S., Kang, D.-H., Feng, L., Nakagawa, T., Kanellis, J., Lan, H., Mazzali, M., & Johnson, R. J. (2002) · Hypertension · doi:10.1161/01.hyp.0000028589.66335.aa · Cited by 563
Self-citationVerdecchia, P., Schillaci, G., Reboldi, G., Santeusanio, F., Porcellati, C., & Brunetti, P. (2000) · Hypertension · doi:10.1161/01.hyp.36.6.1072 · Cited by 558
Two independent mutational events in the loss of urate oxidase during hominoid evolution
Wu, X., Muzny, D. M., Chi Lee, C., & Thomas Caskey, C. (1992) · Journal of Molecular Evolution · doi:10.1007/bf00163854 · Cited by 535
Chemokines and atherosclerosis
Reape, T. J., & Groot, P. H. E. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00346-9 · Cited by 504
Cloning Two Isoforms of Rat Cyclooxygenase: Differential Regulation of Their Expression
Feng, L., Sun, W. Q., Xia, Y. Y., Tang, W. W., Chanmugam, P., Soyoola, E., Wilson, C. B., & Hwang, D. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1601 · Cited by 452
Self-citationSerum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
Alderman, M. H., Cohen, H., Madhavan, S., & Kivlighn, S. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.144 · Cited by 441
Rao, G. N., Corson, M. A., & Berk, B. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93017-6 · Cited by 391
SERUM URIC ACID IN RELATION TO AGE AND PHYSIQUE IN HEALTH AND IN CORONARY HEART DISEASE
GERTLER, M. M., GARN, S. M., & LEVINE, S. A. (1951) · Annals of Internal Medicine · doi:10.7326/0003-4819-34-6-1421 · Cited by 351
Martin, T., Cardarelli, P. M., Parry, G. C. N., Felts, K. A., & Cobb, R. R. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270508 · Cited by 317
Uric acid in chronic heart failure: a marker of chronic inflammation
Leyva, F. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1188 · Cited by 287
Santos, C. X. C., Anjos, E. I., & Augusto, O. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1491 · Cited by 274
Serum uric acid and hypertension: the Olivetti heart study.
Jossa, F., Farinaro, E., Panico, S., Krogh, V., Celentano, E., Galasso, R., Mancini, M., & Trevisan, M. (1994) · PubMed · Cited by 266
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy
Syrjänen, J., Mustonen, J., & Pasternack, A. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.1.34 · Cited by 257
Furukawa, Y., Matsumori, A., Ohashi, N., Shioi, T., Ono, K., Harada, A., Matsushima, K., & Sasayama, S. (1999) · Circulation Research · doi:10.1161/01.res.84.3.306 · Cited by 226
Serum urate and the risk of major coronary heart disease events.
Wannamethee, S. G., Shaper, A. G., & Whincup, P. H. (1997) · Heart · doi:10.1136/hrt.78.2.147 · Cited by 211
A mythology of medical education.
Simpson, M. (1974) · PubMed · Cited by 194
Bagnati, M., Perugini, C., Cau, C., Bordone, R. P., Albano, E., & Bellomo, G. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3400143 · Cited by 190
Serum Uric Acid and Renal Prognosis in Patients with IgA Nephropathy
Ohno, I., Hosoya, T., Gomi, H., Ichida, K., Okabe, H., & Hikita, M. (2001) · Nephron · doi:10.1159/000045939 · Cited by 169
Patterson, R. A., Horsley, E. T. M., & Leake, D. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200407-jlr200 · Cited by 143
ON CHRONIC BRIGHT'S DISEASE, AND ITS ESSENTIAL SYMPTOMS.
Mahomed, F. A. (1879) · The Lancet · doi:10.1016/s0140-6736(02)45936-3 · Cited by 130
Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein
Abuja, P. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00231-8 · Cited by 128
Keulenaer, G. W. D., Ushio‐Fukai, M., Yin, Q., Chung, A. B., Lyons, P. R., Ishizaka, N., Kalpana, R., Taylor, W. R., Alexander, R. W., & Griendling, K. K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.385 · Cited by 92
Stark, V. K., Hoch, J. R., WARNER, T. F. C. S., & Hullett, D. A. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.8.1614 · Cited by 73
Cited by
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Self-citationIs There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Self-citationUric Acid: The Oxidant-Antioxidant Paradox
Sautin, Y. Y., & Johnson, R. J. (2008) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770802138558 · Cited by 972
Self-citationFructose and sugar: A major mediator of non-alcoholic fatty liver disease
Jensen, T., Abdelmalek, M. F., Sullivan, S., Nadeau, K. J., Green, M., Roncal, C., Nakagawa, T., Kuwabara, M., Sato, Y., Kang, D.-H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.019 · Cited by 941
Self-citationFeig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914
Self-citation
Metadata
- Authors
- Kanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., & Johnson, R. J.
- Venue
- Hypertension
- Published
- 2003-06
- Volume
- 41
- Issue
- 6
- Pages
- 1287-1293
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2151834039
- Cited by
- 786
- References
- 37
- FWCI
- 13.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.